138 related articles for article (PubMed ID: 25947926)
1. Bioconversion of (-)-epicatechin, (+)-epicatechin, (-)-catechin, and (+)-catechin by (-)-epigallocatechin-metabolizing bacteria.
Takagaki A; Nanjo F
Biol Pharm Bull; 2015; 38(5):789-94. PubMed ID: 25947926
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of rat intestinal bacteria involved in biotransformation of (-)-epigallocatechin.
Takagaki A; Kato Y; Nanjo F
Arch Microbiol; 2014 Oct; 196(10):681-95. PubMed ID: 24947740
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of (-)-epigallocatechin and (-)-gallocatechin by intestinal bacteria involved in isoflavone metabolism.
Takagaki A; Nanjo F
Biol Pharm Bull; 2015; 38(2):325-30. PubMed ID: 25747993
[TBL] [Abstract][Full Text] [Related]
4. Isolation of catechin-converting human intestinal bacteria.
Kutschera M; Engst W; Blaut M; Braune A
J Appl Microbiol; 2011 Jul; 111(1):165-75. PubMed ID: 21457417
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of (-)-epicatechin, (+)-epicatechin, (-)-catechin, and (+)-catechin by intestinal bacteria involved in isoflavone metabolism.
Takagaki A; Nanjo F
Biosci Biotechnol Biochem; 2016; 80(1):199-202. PubMed ID: 26312950
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a human intestinal bacterium Eggerthella sp. CAT-1 capable of cleaving the C-ring of (+)-catechin and (-)-epicatechin, followed by p-dehydroxylation of the B-ring.
Jin JS; Hattori M
Biol Pharm Bull; 2012; 35(12):2252-6. PubMed ID: 23207778
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria.
Meselhy MR; Nakamura N; Hattori M
Chem Pharm Bull (Tokyo); 1997 May; 45(5):888-93. PubMed ID: 9178524
[TBL] [Abstract][Full Text] [Related]
8. A newly isolated intestinal bacterium involved in the C-ring cleavage of flavan-3-ol monomers and the antioxidant activity of the metabolites.
Wang L; Liu R; Yan F; Chen W; Zhang M; Lu Q; Huang B; Liu R
Food Funct; 2024 Jan; 15(2):580-590. PubMed ID: 37927225
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Interindividual Variability Associated with the Microbial Metabolism of (-)-Epicatechin.
Lessard-Lord J; Roussel C; Guay V; Desjardins Y
J Agric Food Chem; 2023 Sep; 71(37):13814-13827. PubMed ID: 37683128
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Activity of Catechin Metabolites Produced by Intestinal Microbiota on Proliferation of HeLa Cells.
Hara-Terawaki A; Takagaki A; Kobayashi H; Nanjo F
Biol Pharm Bull; 2017; 40(8):1331-1335. PubMed ID: 28769014
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of (-)-epigallocatechin gallate by rat intestinal flora.
Takagaki A; Nanjo F
J Agric Food Chem; 2010 Jan; 58(2):1313-21. PubMed ID: 20043675
[TBL] [Abstract][Full Text] [Related]
12. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium.
Wang LQ; Meselhy MR; Li Y; Nakamura N; Min BS; Qin GW; Hattori M
Chem Pharm Bull (Tokyo); 2001 Dec; 49(12):1640-3. PubMed ID: 11767089
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Commercial Proanthocyanidins. Part 6: Sulfitation of Flavan-3-Ols Catechin and Epicatechin, and Procyanidin B-3.
Noreljaleel AEM; Wilhelm A; Bonnet SL
Molecules; 2020 Oct; 25(21):. PubMed ID: 33126408
[TBL] [Abstract][Full Text] [Related]
14. Catabolism of (+)-catechin and (-)-epicatechin by rat intestinal microbiota.
Takagaki A; Nanjo F
J Agric Food Chem; 2013 May; 61(20):4927-35. PubMed ID: 23621128
[TBL] [Abstract][Full Text] [Related]
15. C-ring cleavage metabolites of catechin and epicatechin enhanced antioxidant activities through intestinal microbiota.
Chen W; Zhu X; Lu Q; Zhang L; Wang X; Liu R
Food Res Int; 2020 Sep; 135():109271. PubMed ID: 32527491
[TBL] [Abstract][Full Text] [Related]
16. Polyphenols in lahpet-so and two new catechin metabolites produced by anaerobic microbial fermentation of green tea.
Shii T; Asada C; Matsuo Y; Saito Y; Tanaka T
J Nat Med; 2014 Apr; 68(2):459-64. PubMed ID: 24458986
[TBL] [Abstract][Full Text] [Related]
17. Isolation of 1-(3',4'-Dihydroxyphenyl)-3-(2″,4″,6″-trihydroxyphenyl)-propan-2-ol from Grape Seed Extract and Evaluation of its Antioxidant and Antispasmodic Potential.
Gleńsk M; Hurst WJ; Glinski VB; Bednarski M; Gliński JA
Molecules; 2019 Jul; 24(13):. PubMed ID: 31277501
[TBL] [Abstract][Full Text] [Related]
18. Absorption, metabolism, distribution and excretion of (-)-epicatechin: A review of recent findings.
Borges G; Ottaviani JI; van der Hooft JJJ; Schroeter H; Crozier A
Mol Aspects Med; 2018 Jun; 61():18-30. PubMed ID: 29126853
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
Lee MJ; Maliakal P; Chen L; Meng X; Bondoc FY; Prabhu S; Lambert G; Mohr S; Yang CS
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1025-32. PubMed ID: 12376503
[TBL] [Abstract][Full Text] [Related]
20. The microbial metabolism of condensed (+)-catechins by rat-caecal microflora.
Groenewoud G; Hundt HK
Xenobiotica; 1986 Feb; 16(2):99-107. PubMed ID: 3962338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
